Understanding the clinical pharmacology of antiviral therapy is pivotal todesigning optimal treatment and prevention strategies. Drug exposure issignificantly influenced by drug interactions, medication taking behavior,and patients’ physiologic and genetic characteristics. These factors arecentral to determining therapeutic efficacy, failure or toxicity. Despitegreat progress, many pharmacologic challenges still exist.The 20th International Workshop on Clinical Pharmacology of Hepatitis,HIV & Other Antiviral Drugs will again provide a platform for discussionsof current topics fundamental to the optimal use of antiviral therapyincluding drug-drug interactions, pharmacokinetics of investigationalagents and existing drugs, pharmacodynamics, drug dosing in specialpopulations, post-marketing surveillance, and regulatory considerations
Medical Education Company